J.Y. Borg

732 total citations
20 papers, 567 citations indexed

About

J.Y. Borg is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, J.Y. Borg has authored 20 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Genetics and 5 papers in Surgery. Recurrent topics in J.Y. Borg's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Platelet Disorders and Treatments (5 papers) and Hemophilia Treatment and Research (4 papers). J.Y. Borg is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Platelet Disorders and Treatments (5 papers) and Hemophilia Treatment and Research (4 papers). J.Y. Borg collaborates with scholars based in France, United Kingdom and New Zealand. J.Y. Borg's co-authors include Robin W. Carrell, David J. Perry, David A. Bruce, Mark R. Wardell, C.W. Chow, Jacques Caen, John M. Hutson, Maurice C. Owen, Claudine Soria and Jennie Soria and has published in prestigious journals such as Journal of Clinical Investigation, FEBS Letters and The American Journal of Gastroenterology.

In The Last Decade

J.Y. Borg

20 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.Y. Borg France	13	321	173	124	119	71	20	567
Martin J. Auger United Kingdom	10	213 0.7×	64 0.4×	200 1.6×	32 0.3×	13 0.2×	17	470
Benjamin N. Hunter United States	5	221 0.7×	88 0.5×	170 1.4×	35 0.3×	22 0.3×	5	477
R.J. Olds United Kingdom	15	685 2.1×	190 1.1×	207 1.7×	124 1.0×	46 0.6×	24	851
Deborah L. Cundiff United States	8	152 0.5×	232 1.3×	270 2.2×	23 0.2×	24 0.3×	9	542
José María Bastida Spain	15	451 1.4×	28 0.2×	114 0.9×	104 0.9×	28 0.4×	56	677
Huimiao Jiang United States	4	248 0.8×	108 0.6×	224 1.8×	40 0.3×	18 0.3×	5	527
Andrew C. Parker United States	7	266 0.8×	190 1.1×	81 0.7×	35 0.3×	17 0.2×	9	467
Jérôme Rollin France	17	357 1.1×	136 0.8×	328 2.6×	400 3.4×	20 0.3×	41	910
C.M. van den Hoogen United States	7	219 0.7×	205 1.2×	111 0.9×	43 0.4×	30 0.4×	12	406
R M Baine United States	8	285 0.9×	59 0.3×	192 1.5×	19 0.2×	42 0.6×	14	510

Countries citing papers authored by J.Y. Borg

Since Specialization

Citations

This map shows the geographic impact of J.Y. Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.Y. Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.Y. Borg more than expected).

Fields of papers citing papers by J.Y. Borg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.Y. Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.Y. Borg. The network helps show where J.Y. Borg may publish in the future.

Co-authorship network of co-authors of J.Y. Borg

This figure shows the co-authorship network connecting the top 25 collaborators of J.Y. Borg. A scholar is included among the top collaborators of J.Y. Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.Y. Borg. J.Y. Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Négrier, Claude, C. Rothschild, J.Y. Borg, et al.. (2016). Post‐authorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study. Vox Sanguinis. 111(4). 383–390. 16 indexed citations

Mathieu‐Dupas, E., H. Lévesque, Yves Gruel, et al.. (2012). The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII. Journal of Thrombosis and Haemostasis. 10(9). 1814–1822. 13 indexed citations

Séror, J, Éric Verspyck, J.Y. Borg, Nadia Berkane, & L. Marpeau. (2010). Valeur prédictive du Doppler utérin et suivi des patientes avec syndrome des anti-phospholipides à haut risque obstétrical : l’expérience rouennaise. Gynécologie Obstétrique & Fertilité. 38(7-8). 447–454. 1 indexed citations

Guédon, C, et al.. (2001). Prothrombotic Inherited Abnormalities Other Than Factor V Leiden Mutation Do Not Play a Role in Venous Thrombosis in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 96(5). 1448–1454. 47 indexed citations

Lévesque, H., J.Y. Borg, P Bossi, et al.. (2001). Lˈhémophilie acquise : approches diagnostiques et thérapeutiques actuelles. La Revue de Médecine Interne. 22(9). 854–866. 15 indexed citations

Mazancourt, Philippe de, et al.. (1996). Activated protein C sensitivity ratio in pregnant women at delivery. British Journal of Haematology. 92(1). 244–246. 38 indexed citations

Hutson, John M., C.W. Chow, & J.Y. Borg. (1996). Intractable constipation with a decrease in substance P-immunoreactive fibres: Is it a variant of intestinal neuronal dysplasia?. Journal of Pediatric Surgery. 31(4). 580–583. 57 indexed citations

Borg, J.Y.. (1996). Can low molecular weight heparin be used in pregnant women?. PubMed. 147 Suppl 1. 45–7. 3 indexed citations

Bruce, David A., David J. Perry, J.Y. Borg, Robin W. Carrell, & Mark R. Wardell. (1994). Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp). Journal of Clinical Investigation. 94(6). 2265–2274. 137 indexed citations

10.

Verroust, F., M.‐F. Torchet, E Fressinaud, et al.. (1993). Comparison of Anti-Human and Anti-Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A. Vox Sanguinis. 64(4). 210–214. 14 indexed citations

11.

Chow, C.W., J.Y. Borg, Virginia Billson, & Brian Lake. (1993). Fetal tissue involvement in the late infantile type of neuronal ceroid lipofuscinosis. Prenatal Diagnosis. 13(9). 833–841. 21 indexed citations

12.

Lévesque, H., J.Y. Borg, N. Cailleux, et al.. (1993). Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.. PubMed. 2(5). 287–8. 25 indexed citations

13.

Vasse, Marc, et al.. (1993). Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes. Blood Coagulation & Fibrinolysis. 4(1). 143–147. 4 indexed citations

14.

Lévesque, H., J.Y. Borg, N. Cailleux, et al.. (1992). Syndrome de Willebrand acquis au cours de l'hypothyroïdie. Étude prospective chez 12 patients. La Revue de Médecine Interne. 13(6). S188–S188. 1 indexed citations

15.

Borg, J.Y., et al.. (1992). [Syndromes of venous mesenteric ischemia: infarction and transient ischemia].. PubMed. 16(8-9). 644–8. 11 indexed citations

16.

Borg, J.Y., et al.. (1991). Functional antithrombin-III variant (41 pro→leu) identified by liquid secondary ion mass spectrometry. Pathology. 23(1). 1–4. 6 indexed citations

17.

Borg, J.Y., et al.. (1990). Antithrombin Rouen‐IV 24 Arg→Cys The amino‐terminal contribution to heparin binding. FEBS Letters. 266(1-2). 163–166. 28 indexed citations

18.

Vasse, Marc, J.Y. Borg, & M. Monconduit. (1989). Protein C : Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities. Thrombosis Research. 56(3). 387–398. 12 indexed citations

19.

Borg, J.Y., Maurice C. Owen, Claudine Soria, et al.. (1988). Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.. Journal of Clinical Investigation. 81(4). 1292–1296. 64 indexed citations

20.

Borg, J.Y., et al.. (1988). New carbohydrate site in mutant antithrombin (7 Ile→Asn) with decreased heparin affinity. FEBS Letters. 237(1-2). 118–122. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact